Migdal Insurance & Financial Holdings Ltd. Fulgent Genetics, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$66.8 - $100.45 $1.06 Million - $1.6 Million	-15,896 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$59.3 - $183.85 $584,994 - $1.81 Million	9,865 Added 163.57%	15,896 $1.54 Million
Q4 2020 Feb 08, 2021	BUY	$31.01 - $52.1 $187,021 - $314,215	6,031 New	6,031 $314,000

Others Institutions Holding FLGT

# of Institutions

201

Shares Held

16.1M

Call Options Held

2.04M

Put Options Held

14K

Black Rock Inc. New York, NY

3.92M
Shares

$78.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.45M
Shares

$29.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.27M
Shares

$25.6 Million
0.01% of portfolio
Dimensional Fund Advisors LP Austin, TX

1.11M
Shares

$22.3 Million
0.01% of portfolio
State Street Corp Boston, MA

794K
Shares

$16 Million
0.0% of portfolio

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account